Allurion Technologies said yesterday it won CE Mark approval in the European Union for its Elipse gastric balloon used for weight loss. The Elipse gastric balloon is made of thin, flexible polymer film and is ingested as a swallowable capsule, making its installation non-surgical. The balloon remains in the stomach for 4 months after which […]
Allurion Technologies
Weight-loss startup raises $1.7M for non-surgical device
Weight-loss devices startup Allurion Technologies closed a $1.7 million funding round, according to the company’s 1st reported filing with the SEC.
The Wellesley, Mass.-based company is working on a balloon, compressed into a swallowable pill, that expands in the stomach.
The balloon remains in the stomach, creating feelings of fullness, until the patient swallows an non-toxic agent that dissolves the balloon. .